TY - JOUR
BT - The Lancet
PY - 2019
SP - 1169 
EP -  1180
T2 - The Lancet
TI - Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
VL - 394
ER -